Product Information

HALOPERIDOL 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1782 per EA under NDC 00378032701. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 10, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HALOPERIDOL 5 MG TABLET

haloperidol
$0.1782per EA

Strength

5 mg/1

NDC

00378032701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

HALOPERIDOL

Approval Type

Generic (ANDA)

FDA Application

ANDA070278

FDA Approved

6/10/1986

TE Code

AB

On Market Since

6/10/1986

Pharmacological Classes

Price Statistics

The NADAC for HALOPERIDOL 5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 52.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1782 per EA
All-time high$0.7992 (Aug 13, 2014)
All-time low$0.1752 (Jun 17, 2026)
52-week high$0.1980
52-week low$0.1752
Median price$0.4446
Average price$0.4512
Largest weekly change+56.9% (Mar 19, 2014)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

-1.1%

1Y

-10.0%

3Y

-49.8%

5Y

-61.9%

All

-52.7%

Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HALOPERIDOL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1782 per EA (NDC 00378032701), effective Aug 19, 2026.

How has the price of HALOPERIDOL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for HALOPERIDOL 5 MG TABLET has declined 52.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HALOPERIDOL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for HALOPERIDOL 5 MG TABLET has ranged from a low of $0.1752 (Jun 17, 2026) to a high of $0.7992 (Aug 13, 2014), with a median of $0.4446 per EA.

Are there cheaper alternatives to HALOPERIDOL 5 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL 5 MG TABLET, is $0.1669 per EA — about 6% below HALOPERIDOL 5 MG TABLET.

Who manufactures HALOPERIDOL 5 MG TABLET?

HALOPERIDOL 5 MG TABLET (NDC 00378032701) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.